NCT02536131

Brief Summary

Longitudinal Investigation of intestinal microbiome, fecal inflammation markers, stress and psychological variables in patients with irritable bowel syndrome and inflammatory bowel disease undergoing gut-directed hypnotherapy (GHT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 31, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

October 5, 2016

Status Verified

October 1, 2016

Enrollment Period

2 years

First QC Date

August 21, 2015

Last Update Submit

October 4, 2016

Conditions

Keywords

PsychosomaticsGastroenterologyPsychoneuroimmunology

Outcome Measures

Primary Outcomes (3)

  • Changes in gut microbiome as assessed through analyzing fecal samples

    Analysis of faeces by taxonomic and functional classification via 16s ribosomal ribonucleic acid (rRNA) sequencing with special regard to commensal microbiota and pathobionts

    7 days

  • Perceived Stress Questionnaire

    10 days

  • Hospital Anxiety and Depression Scale

    Total score as a measure of psychological distress

    7 days

Secondary Outcomes (6)

  • Connor-Davidson Resilience Scale

    10 days

  • Severity Scoring System for Irritable Bowel Syndrome

    10 days

  • Faecal calprotectin

    1 day

  • Harvey-Bradshaw-Index

    2 days

  • Quality of life visual analogue scales

    10 days

  • +1 more secondary outcomes

Study Arms (1)

Study group

OTHER

7-10 sessions gut-directed hypnotherapy within 12 weeks

Other: Gut-directed hypnotherapy

Interventions

relaxation technique with hypnotic induction and suggestions aimed at fostering sense of control, acceptance and calming of bowels.

Also known as: Gut-focused hypnotherapy
Study group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of IBS or IBD
  • Eligible for gut-directed hypnotherapy
  • Adult age (18-89)
  • Sufficient knowledge of german language

You may not qualify if:

  • Severe somatic or psychiatric illness
  • Operations of the GI tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, 1090, Austria

Location

Related Publications (1)

  • Peter J, Fournier C, Durdevic M, Knoblich L, Keip B, Dejaco C, Trauner M, Moser G. A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome. Psychosom Med. 2018 Oct;80(8):698-709. doi: 10.1097/PSY.0000000000000630.

Study Officials

  • Gabriele Moser, MD, Prof

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Gabriele Moser

Study Record Dates

First Submitted

August 21, 2015

First Posted

August 31, 2015

Study Start

August 1, 2014

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

October 5, 2016

Record last verified: 2016-10

Locations